VEDA LAB

Diagnostics Direct, LLC is a specialized provider of FDA 510(k)-cleared, CLIA-waived rapid diagnostic tests for sexually transmitted infections (STIs), with particular expertise in syphilis detection. The company's flagship product, Syphilis Health Check™, is the first and only FDA-cleared rapid syphilis test that delivers results in 10 minutes using fingerstick methodology, eliminating the need for phlebotomy or laboratory readers. Since 2014, Diagnostics Direct has supported public health initiatives to combat the syphilis epidemic by providing point-of-care diagnostic tools that enable healthcare providers and public health agencies to achieve immediate patient identification and treatment initiation. The company offers comprehensive support including on-demand training, implementation protocols, quality control materials, and clinical data resources to healthcare facilities, state health departments, and community health programs.